Cardlytics Continues Profits Contraction Amidst Deteriorating Business Economics (NASDAQ: CDLX)

.Financial article writer recommends selling Cardlytics, Inc. because of declining unit business economics, profits problems, and negative financial styles. Click on for this CDLX improve.